2007
DOI: 10.1038/nature05737
|View full text |Cite
|
Sign up to set email alerts
|

A type III effector ADP-ribosylates RNA-binding proteins and quells plant immunity

Abstract: The bacterial plant pathogen Pseudomonas syringae injects effector proteins into host cells through a type III protein secretion system to cause disease. The enzymatic activities of most of P. syringae effectors and their targets remain obscure. Here we show that the type III effector HopU1 is a mono-ADP-ribosyltransferase (ADP-RT). HopU1 suppresses plant innate immunity in a manner dependent on its ADP-RT active site. The HopU1 substrates in Arabidopsis thaliana extracts were RNA-binding proteins that possess… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

14
340
1
10

Year Published

2008
2008
2018
2018

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 343 publications
(365 citation statements)
references
References 41 publications
14
340
1
10
Order By: Relevance
“…Third, several pathogen effectors have chloroplast localization signals, 24 and in some cases they have been shown to suppress immunity. 25,26 In plants, the molecular events that lead to HR during ETI are partly overlapping with those associated with MTI, including accumulation of SA, ROS and NOI, activation of MAPK cascades, changes in intracellular calcium levels, transcriptional reprogramming and synthesis of antimicrobial compounds. 23 Compared with MTI, ETI is typically an accelerated and amplified response, suggesting that quantitative rather than qualitative differences account for HR induction.…”
Section: Immune Surveillance Systems In Plants and Animalsmentioning
confidence: 99%
“…Third, several pathogen effectors have chloroplast localization signals, 24 and in some cases they have been shown to suppress immunity. 25,26 In plants, the molecular events that lead to HR during ETI are partly overlapping with those associated with MTI, including accumulation of SA, ROS and NOI, activation of MAPK cascades, changes in intracellular calcium levels, transcriptional reprogramming and synthesis of antimicrobial compounds. 23 Compared with MTI, ETI is typically an accelerated and amplified response, suggesting that quantitative rather than qualitative differences account for HR induction.…”
Section: Immune Surveillance Systems In Plants and Animalsmentioning
confidence: 99%
“…Some effectors, particularly bacterial T3SS effectors, are enzymes that biochemically modify host molecules, typically impeding their function or eliminating them (Cunnac et al 2009;Deslandes and Rivas 2012). The enzymatic activities of effectors are diverse and include protease, hydrolase, phosphatase, kinase, transferase, and ubiquitin ligase activities (Shao et al 2003;Abramovitch et al 2006b;Janjusevic et al 2006;Fu et al 2007;Lee et al 2012a;Rodriguez-Herva et al 2012;van Damme et al 2012). Other effectors do not carry enzymatic activities and act by binding host proteins to modulate their functions.…”
Section: Host-cell Targets Of Effectorsmentioning
confidence: 99%
“…T3Es commonly contain sequences addressing specific eukaryotic subcellular localizations (10,11) and enzymatic activities (12)(13)(14)(15)(16)(17) that disrupt and/or suppress PTI. Known targets of T3Es include plasma membrane-localized receptor complexes (13,(18)(19)(20)(21)(22)(23), downstream MAPK cascades (24,25), the stability of defenserelated transcripts (26), phytoalexin biosynthesis (27), and vesicle trafficking (28).…”
mentioning
confidence: 99%